Total Payments
$17,613
2024 Payments
$2,980
Companies
57
Transactions
885
Medicare Patients
7,633
Medicare Billing
$741,564
Payment Breakdown by Category
Food & Beverage$17,498 (99.3%)
Education$115.49 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,498 | 875 | 99.3% |
| Education | $115.49 | 10 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,247 | 62 | $0 (2024) |
| Novo Nordisk Inc | $1,751 | 101 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,271 | 60 | $0 (2024) |
| Lilly USA, LLC | $1,178 | 56 | $0 (2024) |
| ABBVIE INC. | $1,101 | 59 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,001 | 64 | $0 (2022) |
| PFIZER INC. | $809.60 | 76 | $0 (2024) |
| Amgen Inc. | $766.45 | 36 | $0 (2024) |
| Amarin Pharma Inc. | $593.58 | 26 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $526.87 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,980 | 106 | AstraZeneca Pharmaceuticals LP ($459.80) |
| 2023 | $2,494 | 119 | AbbVie Inc. ($347.55) |
| 2022 | $2,856 | 110 | ABBVIE INC. ($399.84) |
| 2021 | $2,208 | 88 | AstraZeneca Pharmaceuticals LP ($490.00) |
| 2020 | $699.31 | 35 | Lilly USA, LLC ($243.89) |
| 2019 | $1,156 | 29 | Astellas Pharma US Inc ($202.48) |
| 2018 | $1,717 | 107 | GlaxoSmithKline, LLC. ($240.27) |
| 2017 | $3,504 | 291 | AstraZeneca Pharmaceuticals LP ($770.45) |
All Payment Transactions
885 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.41 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Hematology | ||||||
| 11/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $130.77 | General |
| Category: Diabetes Care | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.71 | General |
| 11/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Biological | ||||||
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Diabetes Care | ||||||
| 10/19/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $82.52 | General |
| Category: Oncology | ||||||
| 10/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: VACCINES | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,730 | 2,590 | $381,342 | $183,913 |
| 2022 | 16 | 1,796 | 2,538 | $379,881 | $188,165 |
| 2021 | 18 | 1,838 | 2,601 | $377,849 | $181,208 |
| 2020 | 22 | 2,269 | 3,743 | $465,078 | $188,279 |
Total Patients
7,633
Total Services
11,472
Medicare Billing
$741,564
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 518 | 953 | $166,775 | $72,414 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 465 | 828 | $99,360 | $49,898 | 50.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 112 | 112 | $19,600 | $13,589 | 69.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 46 | 46 | $17,894 | $12,979 | 72.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 107 | 107 | $32,421 | $9,521 | 29.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 129 | 129 | $9,675 | $9,279 | 95.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 44 | 44 | $13,640 | $6,745 | 49.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 132 | 132 | $9,108 | $3,819 | 41.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 39 | 41 | $3,239 | $1,663 | 51.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 46 | 46 | $1,748 | $1,331 | 76.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 38 | 80 | $3,360 | $1,298 | 38.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 17 | $1,309 | $721.99 | 55.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 18 | $864.00 | $293.08 | 33.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 21 | $861.00 | $212.40 | 24.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 16 | $1,488 | $151.62 | 10.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 430 | 698 | $121,780 | $59,214 | 48.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 430 | 870 | $103,988 | $50,084 | 48.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 187 | 187 | $32,725 | $23,346 | 71.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 172 | 172 | $52,116 | $15,366 | 29.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 154 | 154 | $11,550 | $10,542 | 91.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 65 | 65 | $20,150 | $10,423 | 51.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 28 | 28 | $10,892 | $7,785 | 71.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 160 | 160 | $11,040 | $4,401 | 39.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $3,825 | $2,404 | 62.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 28 | 32 | $2,528 | $1,303 | 51.5% |
About Dr. Marc Comianos, DO
Dr. Marc Comianos, DO is a Internal Medicine healthcare provider based in Little River, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013965532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Comianos, DO has received a total of $17,613 in payments from pharmaceutical and medical device companies, with $2,980 received in 2024. These payments were reported across 885 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($17,498).
As a Medicare-enrolled provider, Comianos has provided services to 7,633 Medicare beneficiaries, totaling 11,472 services with total Medicare billing of $741,564. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Little River, SC
- Active Since 05/05/2006
- Last Updated 06/24/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1013965532
Products in Payments
- FARXIGA (Drug) $1,019
- XARELTO (Drug) $714.42
- ELIQUIS (Drug) $625.03
- Vascepa (Drug) $593.58
- MOUNJARO (Drug) $535.89
- Ozempic (Drug) $530.02
- ENTRESTO (Drug) $453.19
- UBRELVY (Drug) $421.18
- BEVESPI AEROSPHERE (Drug) $418.50
- JARDIANCE (Drug) $411.61
- TRELEGY ELLIPTA (Drug) $402.28
- VRAYLAR (Drug) $395.47
- REXULTI (Drug) $373.78
- BREZTRI (Drug) $361.51
- AREXVY (Drug) $355.02
- RYBELSUS (Drug) $318.64
- VOQUEZNA (Drug) $301.29
- INVOKANA (Drug) $280.47
- QUVIVIQ (Drug) $273.16
- Otezla (Drug) $261.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Little River
Dr. Yuxuan Mao, M.d., M.s, M.D., M.S
Internal Medicine — Payments: $87,660
Internal Medicine $87,660
Kevin Dineen, Md, MD
Internal Medicine — Payments: $14,769
Internal Medicine $14,769
Dr. Donny Huynh, M.d, M.D
Internal Medicine — Payments: $8,317
Internal Medicine $8,317
Dr. Ruth Wieland, Md, MD
Internal Medicine — Payments: $7,362
Internal Medicine $7,362
Dr. Robert Prinzi, Md, MD
Internal Medicine — Payments: $3,545
Internal Medicine $3,545
Michael Sperling, M.d, M.D
Internal Medicine — Payments: $3,142
Internal Medicine $3,142